Evidence map›Paper›PMID 30622442›Full record

ReviewTheScientificWorldJournal2018

Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction.

J Mayrink, M L Costa, J G Cecatti

Open access · goldAbstract readReview
In one paragraph

Review in TheScientificWorldJournal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Longitudinal fetal growth parameters in women at high risk for pre-eclampsia.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. The Role of ncRNAs in the Immune Dysregulation of Preeclampsia.International journal of molecular sciences · 2023
    Review
  15. A longitudinal study of free leptin index in pre-eclamptic pregnancies.Journal of cellular and molecular medicine · 2023
    Observational
  16. Article
  17. Cell journal · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J MayrinkObstetric Unit, Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil.ORCID 0000-0001-5957-4365
M L CostaObstetric Unit, Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
J G CecattiObstetric Unit, Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil.ORCID 0000-0003-1285-8445
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preeclampsia currently remains one of the leading causes of death and severe maternal morbidity. Although its prevalence is still underestimated in some places due to underreporting, preeclampsia is a disease that health professionals need to know how to deal with and take action. For this reason, the studies about the theme remain along with the advances in their understanding that often implies improvement and change of concepts and conducts. The complexity of its etiology is a challenge and requires further studies for its full understanding. Apparently, poor adaptation of the maternal organism to the conceptus, marked by the nonoccurrence of changes in the uterine spiral arteries, determines a series of systemic repercussions that compound the various forms of preeclampsia presentation. In recent years, the use of acetylsalicylic acid to prevent cases of early onset of the disease has been consolidated and, alongside, studies have advanced the development of accessible and effective methods of identifying women at risk of preeclampsia. The aim of this review is to discuss updates on the occurrence, concept, pathophysiology, repercussion, prevention, and prediction of preeclampsia.

Indexed as

ADAM12 ProteinAdultAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAspirinBiomarkersFemaleGalectinsHumansLaser-Doppler FlowmetryMembrane ProteinsPlacentaPre-EclampsiaPregnancyPregnancy-Associated Plasma Protein-APregnancy ProteinsADAM12 ProteinADAM12 protein, humanAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAspirinBiomarkersFLT1 protein, humanGalectinsLGALS13 protein, humanMembrane ProteinsPAPPA protein, humanPIGF protein, humanPregnancy-Associated Plasma Protein-APregnancy ProteinsVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID30622442
PMCPMC6304478
OpenAlexW2903940163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.